BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1115123)

  • 21. Using loco-regional recurrence as an indicator of the quality of breast cancer treatment.
    Ernst MF; Voogd AC; Coebergh JW; Poortmans PM; Roukema JA
    Eur J Cancer; 2004 Mar; 40(4):487-93. PubMed ID: 14962713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and urinary androgens and risk of breast cancer in postmenopausal women.
    Secreto G; Toniolo P; Berrino F; Recchione C; Cavalleri A; Pisani P; Totis A; Fariselli G; Di Pietro S
    Cancer Res; 1991 May; 51(10):2572-6. PubMed ID: 2021938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Postoperative fever and prognosis in breast cancer].
    Teucher G; Schindler AE
    Arch Geschwulstforsch; 1987; 57(4):309-17. PubMed ID: 3675144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Breast-preserving operations in surgically treatable breast cancer].
    Svastics E; Besznyák I; Rahóty P; Sulyok Z; Molnár L
    Orv Hetil; 1993 May; 134(22):1181-5. PubMed ID: 8506107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ovarian metastases in breast carcinoma].
    Horvath TJ; Schindler AE
    Fortschr Med; 1977 Feb; 95(6):358-60. PubMed ID: 190099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of adjuvant hormonal and cytotoxic chemotherapy.
    Heuson JC
    Acta Chir Belg; 1980; 79(2):89-93. PubMed ID: 7435106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women.
    Grattarola R
    Am J Obstet Gynecol; 1973 Jun; 116(3):423-8. PubMed ID: 4707544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage mastectomy for local and regional recurrence after breast-conserving operation and radiation therapy.
    Osborne MP; Borgen PI; Wong GY; Rosen PP; McCormick B
    Surg Gynecol Obstet; 1992 Mar; 174(3):189-94. PubMed ID: 1542833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Our experience in the surgical treatment of early breast cancer. Results of a prospective study of 204 cases].
    Casolo P; Mosca D; Amorotti C; Raspadori A; Drei B; Di Blasio P; Colli G; De Maria R; De Luca G; Ganz E; Amuso D
    Ann Ital Chir; 1997; 68(2):195-204; discussion 204-5. PubMed ID: 9290010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic factors in breast cancer and recurrence: study using a quantification theory; type-II].
    Murayama Y; Ogiwara H
    Gan No Rinsho; 1984 Apr; 30(4):353-6. PubMed ID: 6727036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Internal endocrine therapy of breast cancer].
    Yoshida M; Miura S
    Gan To Kagaku Ryoho; 1984 May; 11(5):989-98. PubMed ID: 6372698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menopause and breast cancer risk.
    Trichopoulos D; MacMahon B; Cole P
    J Natl Cancer Inst; 1972 Mar; 48(3):605-13. PubMed ID: 5058966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary testosterone values in patients with ovarian metastases from breast cancer.
    Secreto G
    Tumori; 1977; 63(5):457-62. PubMed ID: 601875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormonal therapy with androgenic steroids in diffuse malignant neoplasms of the breast].
    Massidda B; Mascia V; Broccia G; Pasqualucci S; Deplano W; Desogus A; Luxi G; Pellegrini A
    Minerva Med; 1977 Feb; 68(4):235-41. PubMed ID: 320501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of hormone loading tests for assessing the source of hyperestrogenism and the functional state of the ovaries in breast cancer patients in menopause].
    Bogdanova AG; Mezinova NN
    Vopr Onkol; 1979; 25(5):20-3. PubMed ID: 462847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PROPHYLACTIC ENDOCRINE TREATMENT IN CARCINOMA OF THE BREAST.
    NISSEN-MEYER R
    Clin Radiol; 1964 Apr; 15():152-60. PubMed ID: 14140852
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic castration for advanced breast cancer.
    Lee YT
    Am J Surg; 1971 Jul; 122(1):42-9. PubMed ID: 5091853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.